Palbociclib in Patients With Non-Small-Cell Lung Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study
Ahn, Eugene R, Mangat, Pam K, Garrett-Mayer, Elizabeth, Halabi, Susan, Dib, Elie G, Haggstrom, Daniel E, Alguire, Kathryn B, Calfa, Carmen J, Cannon, Timothy L, Crilley, Pamela A, Gaba, Anu G, Marr, Alissa S, Sangal, Ashish, Thota, Ramya, Antonelli, Kaitlyn R, Islam, Samiha, Rygiel, Andrew L, Bruinooge, Suanna S, Schilsky, Richard L
Published in JCO precision oncology (01.11.2020)
Published in JCO precision oncology (01.11.2020)
Get more information
Journal Article
Palbociclib (P) in patients (pts) with non-small cell lung cancer (NSCLC) with CDKN2A alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Ahn, Eugene R, Mangat, Pam K., Garrett-Mayer, Elizabeth, Halabi, Susan, Dib, Elie G., Haggstrom, Daniel Ernest, Alguire, Kathryn B., Alvarez, Ricardo H., Calfa, Carmen Julia, Cannon, Timothy Lewis, Crilley, Pamela A., Gaba, Anu G., Marr, Alissa S., Sangal, Ashish, Thota, Ramya, Antonelli, Kaitlyn R., Islam, Samiha, Rygiel, Andrew Lawrence, Bruinooge, Suanna S., Schilsky, Richard L.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Bevacizumab, pertuzumab, and sandostatin for patients (pts) with advanced neuroendocrine cancers (NET)
Firdaus, Irfan, Shih, Kent C., Zakari, Ahmed, Lang, Evan Z., McCleod, Michael, Alguire, Kathryn B., Peacock, Nancy Walker, Flora, Douglas B., Ruehlman, Peter, Earwood, Chris, Bendell, Johanna C.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article